A detailed history of Legal Advantage Investments, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Legal Advantage Investments, Inc. holds 8,199 shares of TMO stock, worth $4.4 Million. This represents 2.73% of its overall portfolio holdings.

Number of Shares
8,199
Previous 8,199 -0.0%
Holding current value
$4.4 Million
Previous $4.35 Million 9.52%
% of portfolio
2.73%
Previous 2.66%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

BUY
$431.41 - $532.94 $18,119 - $22,383
42 Added 0.51%
8,199 $4.35 Million
Q3 2023

Oct 25, 2023

SELL
$498.29 - $574.41 $43,849 - $50,548
-88 Reduced 1.07%
8,157 $4.13 Million
Q2 2023

Jul 31, 2023

BUY
$508.46 - $591.13 $216,095 - $251,230
425 Added 5.43%
8,245 $4.3 Million
Q1 2023

Apr 24, 2023

BUY
$535.0 - $604.82 $18,725 - $21,168
35 Added 0.45%
7,820 $4.51 Million
Q3 2022

Nov 03, 2022

BUY
$507.19 - $604.49 $43,111 - $51,381
85 Added 1.1%
7,785 $3.95 Million
Q2 2022

Jul 26, 2022

BUY
$500.9 - $612.21 $250,450 - $306,105
500 Added 6.94%
7,700 $4.18 Million
Q1 2022

May 06, 2022

BUY
$524.0 - $644.92 $65,500 - $80,615
125 Added 1.77%
7,200 $4.25 Million
Q4 2021

Feb 08, 2022

SELL
$569.0 - $667.24 $68,280 - $80,068
-120 Reduced 1.67%
7,075 $4.72 Million
Q3 2021

Oct 25, 2021

BUY
$509.53 - $609.78 $50,953 - $60,978
100 Added 1.41%
7,195 $4.11 Million
Q2 2021

Jul 26, 2021

BUY
$441.0 - $508.24 $882 - $1,016
2 Added 0.03%
7,095 $3.58 Million
Q1 2021

May 06, 2021

BUY
$439.85 - $518.83 $4,398 - $5,188
10 Added 0.14%
7,093 $3.24 Million
Q4 2020

Jan 28, 2021

BUY
$435.06 - $527.66 $3.08 Million - $3.74 Million
7,083 New
7,083 $3.3 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $210B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Legal Advantage Investments, Inc. Portfolio

Follow Legal Advantage Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal Advantage Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legal Advantage Investments, Inc. with notifications on news.